Similipal Pharmaceutical Private Limited
About Similipal Pharmaceutical Private Limited
Data last updated:
Similipal Pharmaceutical Private Limited is a private limited company based in Baripada, Orissa, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 June 2023.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U21009OD2023PTC042938.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sabita Mohanta and Sanjib Kumar Mohanta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – Bidjadhar Mohanta, Bahadurpur Plot No 168, Baripada, Orissa, India – 757049.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O – Bidjadhar Mohanta, Bahadurpur Plot No 168, Baripada, Orissa, India – 757049
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Similipal Pharmaceutical Private Limited FY 2025 filings available
Similipal Pharmaceutical Private Limited reported revenue of ₹253 for FY 2025.
Financial Statement Summary of Similipal Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | •••• | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | •••• | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Similipal Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | •••• | •••• |
| Net Profit Margin | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Similipal Pharmaceutical are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Similipal Pharmaceutical Private Limited
Similipal Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sabita Mohanta | Director | 13 Jun 2023 | 3 Years 3 Months | Current |
| Sanjib Kumar Mohanta | Additional Director | 30 Oct 2025 | 0 Years 11 Months | Current |
Charges & Borrowings of Similipal Pharmaceutical Private Limited
Similipal Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Similipal Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Similipal Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Similipal Pharmaceutical Private Limited
Similipal Pharmaceutical Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Sanjib Kumar Mohanta was appointed as Additional Director on 30 Oct 2025.
Credit Ratings, Litigation & Regulatory Alerts for Similipal Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Similipal Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Similipal Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Similipal Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Similipal Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Similipal Pharmaceutical Private Limited
Similipal Pharmaceutical is an active private limited company based in Baripada, Orissa, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 June 2023 (3+ years old) and is registered under CIN U21009OD2023PTC042938.
Similipal Pharmaceutical has 2 current directors:
- Sabita Mohanta - Director
- Sanjib Kumar Mohanta - Additional Director
The CIN (Corporate Identification Number) of Similipal Pharmaceutical is U21009OD2023PTC042938. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Similipal Pharmaceutical was incorporated on 13 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Cuttack.
Sanjib Kumar Mohanta was appointed as Additional Director on 30 Oct 2025. Sanjit Mohanta ceased to be Director on 30 Oct 2025. Sabita Mohanta was appointed as Director on 13 Jun 2023. Similipal Pharmaceutical has 4 board changes on record in total.
The registered office of Similipal Pharmaceutical is at CO – Bidjadhar Mohanta, Bahadurpur Plot No 168, Baripada, Orissa, India – 757049.
Similipal Pharmaceutical has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh.
Similipal Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
No. Similipal Pharmaceutical is not listed on any stock exchange. It is an unlisted company.
Similipal Pharmaceutical can be reached at its registered office: CO – Bidjadhar Mohanta, Bahadurpur Plot No 168, Baripada, Orissa, India – 757049.